Family Medicine · Los Angeles, CA
NPI
1639121981
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
5250 Santa Monica Blvd Ste 310
Los Angeles, CA, 90029
Phone (323) 663-9831
Groups this clinician bills Medicare through
Medicare paid, 2024
$336K
10,036 services
Medicare patients, 2024
562
Average age 74
Drug cost, 2024
$4.7M
38,435 prescriptions
Company payments, 2025
$1,858
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hovanes J Ter-Zakarian was code 99442 (telephone services), 2,406 times for 394 patients. In total Hovanes J Ter-Zakarian billed 10,036 services in 78 codes, and Medicare paid $336K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-12-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99442 Telephone Services | Office | 2,406 | 394 | $55.37 | $133K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,262 | 29 | $0.10 | $231 |
| 99214 Office E&M - Established | Office | 1,228 | 436 | $88.29 | $108K |
| 36415 Venipuncture Blood Collection | Office | 949 | 395 | $8.65 | $8,209 |
| 95004 Test - Miscellaneous | Office | 933 | 13 | $2.95 | $2,754 |
| 99213 Office E&M - Established | Office | 826 | 353 | $63.53 | $52K |
| 96372 Injection Administration | Office | 182 | 54 | $10.95 | $1,993 |
| 20610 Joint Injection | Office | 80 | 29 | $49.77 | $3,982 |
| 82962 Clinical Chemistry | Office | 77 | 54 | $3.21 | $247 |
| 99441 Telephone Services | Office | 62 | 55 | $43.35 | $2,688 |
| 93000 Electrocardiogram | Office | 55 | 50 | $11.22 | $617 |
| 71046 X-ray - Chest | Office | 40 | 33 | $22.57 | $903 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 38 | 16 | $3.85 | $146 |
| 99204 Office E&M - New | Office | 28 | 28 | $87.85 | $2,460 |
| 83013 Clinical Chemistry | Office | 28 | 27 | $66.01 | $1,848 |
By year: 2022 $546K for 8,612 services; 2023 $413K for 7,781 services; 2024 $336K for 10,036 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 949 | 395 | $8.65 | $8,209 |
| 82962 Clinical Chemistry | 77 | 54 | $3.21 | $247 |
| 83013 Clinical Chemistry | 28 | 27 | $66.01 | $1,848 |
| 83014 Clinical Chemistry | 28 | 27 | $7.70 | $216 |
| 81003 Clinical Chemistry | 21 | 21 | $2.20 | $46.2 |
| 87426 Immunoassay | 17 | 17 | $34.62 | $589 |
Medicare prescription drug claims, 2024
In 2024, the drug Hovanes J Ter-Zakarian prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,323 prescriptions and refills. In total Hovanes J Ter-Zakarian wrote 38,435 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,323 | 1,414 | 152 | $3,554 |
| Amlodipine Besylate Generic | 1,070 | 1,115 | 119 | $770 |
| Rosuvastatin Calcium Generic | 906 | 1,004 | 97 | $2,593 |
| Metoprolol Succinate Generic | 881 | 930 | 95 | $3,307 |
| Diclofenac Sodium Generic | 851 | 863 | 146 | $323K |
| Clonidine Hcl Generic | 850 | 855 | 93 | $1,508 |
| Ibuprofen Generic | 796 | 811 | 132 | $3,704 |
| Omeprazole Generic | 781 | 794 | 99 | $1,468 |
| Gabapentin Generic | 777 | 811 | 83 | $3,462 |
| Metformin Hcl Generic | 756 | 811 | 92 | $3,585 |
| Tamsulosin Hcl Generic | 678 | 706 | 71 | $2,084 |
| Amlodipine Besylate-Benazepril Amlodipine Besylate/Benazepril | 677 | 724 | 72 | $3,674 |
| Furosemide Generic | 604 | 641 | 65 | $654 |
| Hydralazine Hcl Generic | 601 | 613 | 67 | $2,188 |
| Meclizine Hcl Generic | 598 | 605 | 67 | $2,653 |
Brand drugs: 5,723 claims; generic drugs: 32,086 claims; opioid claims: 684.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hovanes J Ter-Zakarian $1,858 ($1,858 in general payments such as food, travel and fees) from 22 companies. The largest payer was Amgen Inc. with $275.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 22 | $275 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $247 |
| Ardelyx, Inc. ARDX | 7 | $214 |
| Abbvie Inc. ABBV | 8 | $206 |
| Sumitomo Pharma America, Inc. 4506.T | 5 | $127 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $125 |
| Aimmune Therapeutics, Inc. | 3 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $70.28 |
| Lilly USA, LLC LLY | 2 | $58.89 |
| Esperion Therapeutics, Inc. ESPR | 3 | $55.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.